Table 4

Change in life expectancy with disability (LED) at age 30 because of smoking elimination (sensitivity analyses)4-151

Men Women
Baseline −0.9−1.1
First set: pooling of datasets
1 Adj for institutionalisation4-152 −0.9−1.0
2 Adj incidence in men4-153 −1.0NA
Second set: 50% sensitivity margins 4-154
1 Incidence−1.3, −0.5−1.5, −0.6
2 Recovery−1.0, −0.7−1.2, −0.9
3 Mortality non-dependent−0.9, −0.8−1.1, −1.0
4 Mortality dependent−1.0, −0.8−1.1, −1.0
Third set: RRs
1 No excess risks for recovery4-1 −0.6−0.8
2 Only significant effects4-2 −1.2−1.3
3 Excluding chronic conditions4-3 −1.3−1.4
4 Sex specific RR of incidence4-4 −0.4−1.6
5 Reduction RRs by 50% above
 age 70		−0.9−1.0

  • ↵4-151 Figures are rounded to 0.1.

  • ↵4-152 Adjustment for underestimation population in institutions above age 76: age 30–75: no change; age 76–85: mortality among disabled * 1.1; recovery * 0.9; age 86–95: mortality among disabled * 1.2; recovery * 0.8; age 96+: mortality from disabled * 1.3; recovery * 0.7.

  • ↵4-153 Using level of incidence of disability based solely on the GLOBE study.

  • ↵4-154 (1–RR) + 50%; (1–RR)—50%.

  • ↵4-1 RR of recovery 1, other RRs as in baseline.

  • ↵4-2 RRs of mortality among non-disabled and for mortality among disabled 1, other RR as in baseline.

  • ↵4-3 Persons who reported to have (had) serious heart diseases, cancer, diabetes mellitus, stroke, chronic obstructive lung disease (COPD) or cancer at baseline were excluded.

  • ↵4-4 RR of incidence 1.35 in men and 2.35 in women. NA, not applicable.